KRT88P and infection: Despite different vaccination regimes, vaccine efficacy (VE) against chronic infection remains high in this population (94–96%) [16]–[19] although infection defined by the sole presence of hepatitis B core antibody (anti-HBc) have occurred in vaccinated subjects [16].